- Home
- AVXL vs HY Comparison
AVXL vs HY Comparison
Compare AVXL & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- HY
- Stock Information
- Founded
- AVXL 2004
- HY 1991
- Country
- AVXL United States
- HY United States
- Employees
- AVXL N/A
- HY N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- HY Construction/Ag Equipment/Trucks
- Sector
- AVXL Health Care
- HY Industrials
- Exchange
- AVXL Nasdaq
- HY Nasdaq
- Market Cap
- AVXL 750.3M
- HY 735.1M
- IPO Year
- AVXL N/A
- HY N/A
- Fundamental
- Price
- AVXL $9.31
- HY $38.30
- Analyst Decision
- AVXL Strong Buy
- HY Strong Buy
- Analyst Count
- AVXL 2
- HY 2
- Target Price
- AVXL $44.00
- HY $80.00
- AVG Volume (30 Days)
- AVXL 1.2M
- HY 85.8K
- Earning Date
- AVXL 05-08-2025
- HY 05-06-2025
- Dividend Yield
- AVXL N/A
- HY 3.64%
- EPS Growth
- AVXL N/A
- HY 11.05
- EPS
- AVXL N/A
- HY 8.04
- Revenue
- AVXL N/A
- HY $4,308,200,000.00
- Revenue This Year
- AVXL N/A
- HY N/A
- Revenue Next Year
- AVXL N/A
- HY $3.75
- P/E Ratio
- AVXL N/A
- HY $4.79
- Revenue Growth
- AVXL N/A
- HY 4.61
- 52 Week Low
- AVXL $3.25
- HY $34.13
- 52 Week High
- AVXL $14.44
- HY $84.44
- Technical
- Relative Strength Index (RSI)
- AVXL 55.97
- HY 39.33
- Support Level
- AVXL $8.61
- HY $36.50
- Resistance Level
- AVXL $9.17
- HY $39.30
- Average True Range (ATR)
- AVXL 0.67
- HY 2.14
- MACD
- AVXL 0.09
- HY 0.32
- Stochastic Oscillator
- AVXL 80.67
- HY 65.36
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.